Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Improved Use of Antibiotic Guidelines in Hospital Environment

This study has been completed.
Information provided by:
Katholieke Universiteit Leuven Identifier:
First received: August 7, 2007
Last updated: December 17, 2010
Last verified: July 2010
The purpose of this study is to determine if the use of antibiotic guidelines and thus antibiotics can be improved through a description of possible barriers leading to tailored interventions.

Community-Acquired Pneumonia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Improved Use of Antibiotic Guidelines in in Hospital Environment: Research on an Implementation Model and the Role of the Hospital Pharmacist.

Resource links provided by NLM:

Further study details as provided by Katholieke Universiteit Leuven:

Enrollment: 823
Study Start Date: October 2007
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients admitted to the hospital with a diagnosis of community-acquired pneumonia or community-acquired pyelonephritis

Inclusion Criteria:

  • Diagnosed community-acquired pneumonia (CAP)
  • Diagnosed community-acquired pyelonephritis

Exclusion Criteria:

  • CAP: hospital-acquired pneumonia; patients transferred from other hospital; death within 24h, aspiration pneumonia, immunocompromised status, palliative status, admission due to social reasons
  • Pyelonephritis: urinary tract with functional or physical abnormalities, urinary catheterisation, pregnancy, (immunocompromised status, palliative status, admission due to social reasons and history of renal transplant.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00512772

Ziekenhuis Oost-Limburg
Genk, Belgium, 3600
Universitair Ziekenhuis Gasthuisberg
Leuven, Belgium, 3000
Sponsors and Collaborators
Katholieke Universiteit Leuven
Principal Investigator: Pieter-Jan Cortoos, PharmD Katholieke Universiteit Leuven
Study Director: Gert Laekeman, PhD Katholieke Universiteit Leuven
  More Information

Responsible Party: Pieter-Jan Cortoos, PharmD, Katholieke Universiteit Leuven Identifier: NCT00512772     History of Changes
Other Study ID Numbers: B32220072383
Study First Received: August 7, 2007
Last Updated: December 17, 2010

Keywords provided by Katholieke Universiteit Leuven:
Time series

Additional relevant MeSH terms:
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Anti-Bacterial Agents
Anti-Infective Agents processed this record on April 28, 2017